To explore and analyze the safety signals of irinotecan and fluorouracil.
The adverse drug reaction (ADR) reports with irinotecan and fluorouracil as suspects included in the FDA adverse event reporting system (FAERS) from January 2004 to September 2021 were selected. The ADR signals were detected by reporting odds ratio and proportional reporting signals.
For the primary screening, 583, 1 239 and 674 preferred term (PT) were obtained by irinotecan, fluorouracil and the combination of two drugs, respectively. The top 3 PT in the number of reports of the combination of two drugs were diarrhea (5.88%), neutropenia (3.41%) and nausea (3.26%), respectively. After secondary screening, 28, 70 and 60 PT were obtained by irinotecan, fluorouracil and the combination of two drugs, and 10, 17 and 13 system organ class were involved, respectively. In the double-screened PT cholinergic syndrome, the reporting odds ratio was 127.4 and 95% confidence interval was (82.9, 195.6). By comparing the Venn diagram of primary screening and secondary screening, the overlap of PT with prominent signal was significantly reduced among irinotecan, fluorouracil and the combination of two drugs.
When using single drug, ADR is more prominent.
| 科 Family | 属数 Number of genus | 种数 Number of species | 占总种数比例 Percentage of total species (%) | 属 Genus | 种数 Number of species | 占总种数比例 Percentage of total species (%) |
|---|---|---|---|---|---|---|
| 鹅膏菌科Amanitaceae | 2 | 11 | 5.26 | 鹅膏菌属 Amanita | 10 | 4.78 |
| 小菇科 Mycenaceae | 2 | 12 | 5.74 | 丝盖伞属 Inocybe | 5 | 2.39 |
| 多孔菌科 Polyporaceae | 8 | 14 | 6.70 | 蜡蘑属 Laccaria | 5 | 2.39 |
| 红菇科 Russulaceae | 3 | 23 | 11.00 | 小皮伞属 Marasmius | 6 | 2.87 |
| 小菇属 Mycena | 11 | 5.26 | ||||
| 光柄菇属 Pluteus | 5 | 2.39 | ||||
| 红菇属 Russula | 17 | 8.13 | ||||
| 栓菌属 Trametes | 5 | 2.39 |